A Miniaturized Assay to Evaluate Plasmodium cynomolgi and Plasmodium knowlesi as Models for Prioritizing Plasmodium vivax Vaccine Targets
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf136 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Sheena Dass und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Plasmodium knowlesi, Malaria Vaccines, Plasmodium vivax, Malaria, Vivax. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, National Institutes of Health/National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Plasmodium vivax vaccine discovery lags behind Plasmodium falciparum due to the absence of a reliable in vitro culture system. We developed a miniature 384-well assay for the evolutionarily related parasite species Plasmodium cynomolgi and Plasmodium knowlesi, deploying it for screening invasion inhibition efficacy of antibodies elicited against 8 P. vivax proteins. All 8 antibodies showed consistent inhibition across both P. knowlesi and P. cynomolgi species, correlating with inhibition in ex vivo P. vivax isolates. The use of simian malaria parasites and this assay represent a robust, high-throughput method for prioritizing P. vivax blood-stage vaccine candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
- Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
- Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
- Global Health and Tropical Medicine, Associate Laboratory in Translation and Innovation Towards Global Health, Institute of Hygiene and Tropical Medicine, NOVA University of Lisbon, Lisbon, Portugal.
ORCID-Profile: Marcelo U Ferreira, Julian C Rayner, Manoj T Duraisingh
Förderung
- NIH HHS
- NIAID NIH HHS
- National Institutes of Health/National Institute of Allergy and Infectious Diseases
Zitieren
APA
Dass, S., Kundu, P., Naskar, D., Kanjee, U., Ferreira, M. U., Rayner, J. C., & Duraisingh, M. T. (2025). A Miniaturized Assay to Evaluate Plasmodium cynomolgi and Plasmodium knowlesi as Models for Prioritizing Plasmodium vivax Vaccine Targets. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf136
Vancouver
Dass S, Kundu P, Naskar D, Kanjee U, Ferreira MU, Rayner JC, et al. A Miniaturized Assay to Evaluate Plasmodium cynomolgi and Plasmodium knowlesi as Models for Prioritizing Plasmodium vivax Vaccine Targets. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf136
BibTeX
@article{Dass2025,
author = {Dass, Sheena and Kundu, Prasun and Naskar, Deboki and Kanjee, Usheer and Ferreira, Marcelo U and Rayner, Julian C and Duraisingh, Manoj T},
title = {A Miniaturized Assay to Evaluate Plasmodium cynomolgi and Plasmodium knowlesi as Models for Prioritizing Plasmodium vivax Vaccine Targets},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf136}
}
EUVIMED